Research and News

Research

News

07/21/2021
The State of Open Source Hardware 2021

 

07/01/2021
Technology Law & Policy Clinic Student Attorneys Assist the Open Source Hardware Association (OSHWA) on Intellectual Property Matters

 

06/30/2021
Food and Drug Administration Takes First-Ever Enforcement Action To Ensure Clinical Trial Transparency, Following NYU Technology Law & Policy Clinic’s Work with Universities Allied for Essential Medicines (UAEM)

 

06/29/2021
Technology Law & Policy Clinic Students Represent iFixit To File Comment with Copyright Office and Protect the Public’s Right To Repair

 

06/28/2021
Technology Law & Policy Clinic Helps the Internet Archive Answer Congressional Questions on the Digital Millennium Copyright Act (DMCA)

 

06/25/2021
Technology Law & Policy Clinic Partners with ACLU on Amicus Brief Against Long-Term Police “Pole Camera” Surveillance

 

06/24/2021
Technology Law & Policy Clinic Partners with ACLU on Amicus Brief That Maps the Limits of Law Enforcement’s Ability To Search Digital Devices

 

06/23/2021
Technology Law & Policy Clinic Supports ml5.js in Developing a New Ethical Open Source Software License and Code of Conduct for Machine Learning

 

06/23/2021
Technology Law & Policy Clinic Celebrates Students’ Pro Bono Work

 

05/06/2021
Vaccine Nationalism: What Is It and How Is It Playing Out During COVID-19?
Teen Vogue
Expert: Navya Dasari

 

04/28/2021
For the first time, the FDA may fine a drug maker for failing to post clinical trial results
Stat News
Expert: Christopher Morten

 

04/27/2021
Vaccine IP Enforcement Takes Stage in Global Immunization Fight
Bloomberg Law
Expert: Christopher Morten

 

04/22/2021
Moderna’s Pledge Not to Enforce the Patents on Their COVID-19 Vaccine Is Worthless
Jacobin
Expert: Christopher Morten

 

04/21/2021
Law pro­fes­sors call for FDA to dis­close all safe­ty and ef­fi­ca­cy da­ta for drugs
Endpoint News
Expert: Christopher Morten

 

04/21/2021
Vaccine patent gives US government 'leverage' over manufacturers
Financial Times
Expert: Christopher Morten

 

04/19/2021
How Did a Self-Taught Linguist Come to Own an Indigenous Language?
The New Yorker
Expert: Jane Anderson

 

04/08/2021
Announcing Interoperability and Portability in the Wild: Lessons from the Data Sharing Practitioners Workshop
Experts: Gabriel Nicholas

 

04/06/2021
How Google’s Big Supreme Court Victory Could Change Software Forever
Time
Expert: Jeanne Fromer

 

04/05/2021
6 Things To Know About High Court's Google-Oracle Ruling
Law360
Expert: Jeanne Fromer

 

04/01/2021
US government does not own any remdesivir patents, GAO report finds
Endpoint News
Expert: Christopher Morten

 

03/31/2021
The U.S. government doesn’t have patent rights to Gilead’s remdesivir, despite investing millions in research
Stat News
Expert: Christopher Morten

 

03/30/2021
"What to Know About New York's 'Vaccine Passport"
WNYC: The Brian Lehrer Show (audio)
Expert: Albert Fox Cahn

 

03/29/2021
Covid-19 Vaccine Deal-Making Is Fleeting Game Changer for Pharma
Bloomberg Law
Expert: Christopher Morten

 

03/25/2021
HHS is urged to use its patents for the Moderna Covid-19 vaccine to widen global access
Stat News
Expert: Christopher Morten

 

03/21/2021
Rich Countries Signed Away a Chance to Vaccinate the World
New York Times
Expert: Christopher Morten

 

03/17/2021
Patent Reform for Social Justice
Experts: Ethan Lin and Christopher Morten

 

 

03/10/2021
Marvel's Punisher Problem
Newsweek
Expert: Jeanne Fromer

 

02/01/2021
Stitching Together a Solution: Lessons from the Open Source Hardware Response to COVID-19
Expert: Michael Weinberg

 

 

01/27/2021
COVID-19 drug remdesivir has been a big win for Gilead — and it got a boost from taxpayers
SF Chronicle
Expert: Christopher Morten

 

01/26/2021
This professor wrote a manual for using a little-known federal law for lowering drug prices
Stat News
Expert: Christopher Morten

2020 News Archive

2019 News Archive